Biktarvy, formally known as bictegravir sulfate, is a powerful single-tablet regimen for controlling HIV infection. This medication integrates three crucial antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It functions by inhibiting the the viral ability to multiply within the body, considerably reducing the viral load